Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

Articles written by Polyplus-transfection featuring Généthon:

Généthon and Polyplus-transfection team up to contribute to researching gene therapies for DMD

Généthon and Polyplus-transfection team up to contribute to researching gene therapies for Duchenne Muscular Dystrophy (Article in Pharmaceutical Manufacturing). Read more…

PEI-mediated virus production

Advanced therapy medicinal products (ATMPs) including gene- and cell therapy-based medicines are experiencing resurgence due to the introduction of “next generation” transfer viral vectors, which have demonstrated improved safety and efficacy. Adeno-Associated Virus (AAV) and Lentivirus have seen considerable increase in use as gene therapy vectors and are often produced using PEI-mediated transient transfection, with PEIpro® and PEIpro®-HQ. Read more…

Généthon's website